NeueHealth, Inc.
NYSE:NEUE Voorraadrapport
Marktkapitalisatie: US$41.7m
NeueHealth Dividenden en inkoop
Dividend criteriumcontroles 0/6 NeueHealth heeft geen dividenduitkeringen gedaan.
Belangrijke informatie
0.005%
Terugkoop Rendement
Totaal aandeelhoudersrendement 0.005% Toekomstig dividendrendement 0% Dividendgroei n/a Volgende betaaldatum dividend n/a Ex-dividenddatum n/a Dividend per aandeel n/a Uitbetalingsratio n/a
Recente updates van dividend en inkoop
Toon alle updates
Third quarter 2024 earnings released: US$6.78 loss per share (vs US$72.52 loss in 3Q 2023) Nov 08
NeueHealth, Inc. Reaffirms Earnings Guidance for the Year 2024 Nov 08
NeueHealth, Inc. to Report Q3, 2024 Results on Nov 07, 2024 Oct 17
Insufficient new directors Sep 01
Second quarter 2024 earnings released: US$6.42 loss per share (vs US$8.55 loss in 2Q 2023) Aug 08
NeueHealth, Inc. Updates Earnings Guidance for the Year 2024 Aug 07
NeueHealth, Inc. to Report Q2, 2024 Results on Aug 07, 2024 Jul 18
New major risk - Financial position Jul 02 NeueHealth, Inc. announced that it has received $150 million in funding Jun 24
New minor risk - Shareholder dilution May 14 NeueHealth, Inc. Reaffirms Earnings Guidance for the Year 2024
First quarter 2024 earnings released: US$2.31 loss per share (vs US$9.04 loss in 1Q 2023) May 08
NeueHealth, Inc. to Report Q1, 2024 Results on May 08, 2024 Apr 20
NeueHealth, Inc., Annual General Meeting, May 02, 2024 Apr 02
Vice Chairman recently sold US$59k worth of stock Mar 14
New minor risk - Shareholder dilution Mar 10
New major risk - Negative shareholders equity Mar 07
Full year 2023 earnings released: US$70.72 loss per share (vs US$98.28 loss in FY 2022) Mar 07
NeueHealth, Inc. Provides Earnings Guidance for the Year 2024 Mar 06
NeueHealth, Inc. to Report Q4, 2023 Results on Mar 06, 2024 Feb 21
Third quarter 2023 earnings released: US$72.52 loss per share (vs US$40.11 loss in 3Q 2022) Nov 09
Bright Health Group, Inc. Provides Earnings Guidance for the Full Year 2023 Nov 08
New major risk - Revenue and earnings growth Oct 27
Bright Health Group, Inc. to Report Q3, 2023 Results on Nov 07, 2023 Oct 14
Bright Health Group, Inc. Announces Leaving of Jeff Cook as Chief Operating Officer, Effective October 13, 2023 Sep 22
Consensus EPS estimates upgraded to US$51.32 loss Sep 01
Second quarter 2023 earnings: EPS and revenues miss analyst expectations Aug 10
Bright Health Group, Inc. Revises Its Financial Outlook for 2023 Aug 10
Bright Health Group, Inc. to Report Q2, 2023 Results on Aug 09, 2023 Jul 18
Price target increased by 47% to US$200 Jun 16
Florence Labs, Inc. acquired Zipnosis, Inc. from Bright Health Group, Inc. (NYSE:BHG). May 25
Price target decreased by 14% to US$1.70 May 13
Bright Health Group, Inc. Provides Earnings Guidance for the Full Year 2023 May 10
First quarter 2023 earnings: EPS and revenues miss analyst expectations May 10
Bright Health Group Announces Chief Financial Officer Changes May 05
Vice Chairman recently sold US$158k worth of stock Mar 17
Price target decreased by 24% to US$1.50 Mar 12
Consensus EPS estimates fall by 14% Mar 08
Full year 2022 earnings released: US$1.23 loss per share (vs US$3.02 loss in FY 2021) Mar 02
Bright Health Group, Inc. to Report Q4, 2022 Results on Mar 01, 2023 Feb 11
Bright Health Group: Stock Price Has Been Too Heavily Beaten Down Jan 19
Bright Health Group expects FY23 revenue to be below consensus Jan 10
Independent Director recently bought US$248k worth of stock Dec 18
Bright Health Group Receives Continued Listing Standard Notice from NYSE Dec 13
Bright Health receives non-compliance notice from NYSE Dec 12
Independent Lead Director recently bought US$294k worth of stock Nov 16
Price target decreased to US$2.07 Nov 16
High number of new directors Nov 16
Third quarter 2022 earnings: EPS and revenues miss analyst expectations Nov 10 Bright Health Group, Inc. Reports Goodwill Impairment for the Three Months Ended September 30, 2022
Bright Health Group reports Q3 mixed earnings; revises Fy22 guidance Nov 09
Bright Health Group, Inc. to Report Q3, 2022 Results on Nov 09, 2022 Oct 20 Bright Health Group, Inc. announced that it has received $175 million in funding from a group of investors Oct 19
Bright Health Group, Inc. Provides Revenue Guidance for the Year 2023
Bright Health narrows footprint to only offer Medicare Advantage in California, Florida Oct 11
Analysts Have Been Trimming Their Bright Health Group, Inc. (NYSE:BHG) Price Target After Its Latest Report Aug 13
Second quarter 2022 earnings: EPS and revenues miss analyst expectations Aug 11
Bright Health Group, Inc. Provides Revenue Guidance for the Full Year 2022 Aug 11
Bright Health Group, Inc. to Report Q2, 2022 Results on Aug 10, 2022 Jul 28
Bright Health Group Takes Cost Actions To Effect Turnaround Jul 21
Price target decreased to US$2.76 Jul 05 Bright Health Group, Inc.(NYSE:BHG) dropped from Russell 2000 Growth Index
Bright Health Group Expands Executive Team as It Drives Performance in Scaled Businesses May 18
Consensus forecasts updated May 11
First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind May 05
High number of new directors Apr 27
Bright Health Group, Inc. to Report Q1, 2022 Results on May 04, 2022 Apr 20
Bright Health Group, Inc., Annual General Meeting, May 13, 2022 Apr 16
Consensus forecasts updated Mar 09
Bright Health Group, Inc. Provides Earnings Guidance for the Year 2022 Mar 04
Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind Mar 04 Bright Health Group, Inc. Provides Earnings Guidance for the Year 2022
Bright Health Group, Inc. to Report Q4, 2021 Results on Mar 02, 2022 Feb 15
Bright Health Group Announces Executive Changes, Effective March 11, 2022 Feb 13
Pomerantz LLP Files A Class Action Lawsuit Against Bright Health Group, Inc Feb 10
Pomerantz LLP Files A Class Action Lawsuit Against Bright Health Group, Inc Feb 09
Pomerantz Law Firm Announces the Filing of A Class Action Against Bright Health Group, Inc Jan 07
Bright Health Group, Inc. announced that it has received $750 million in funding from CIGNA Health and Life Insurance Company, New Enterprise Associates, Inc. Jan 05
Bright Health Group: Examining A Dumpster Fire Jan 04
Third quarter 2021 earnings released: US$0.48 loss per share Nov 14
Independent Director recently bought US$959k worth of stock Sep 15
Independent Director recently bought US$479k worth of stock Sep 12
Stabiliteit en groei van betalingen
Stabiel dividend: Er zijn onvoldoende gegevens om te bepalen of het dividend per aandeel van NEUE in het verleden stabiel is geweest.
Groeiend dividend: Er zijn onvoldoende gegevens om te bepalen of de dividendbetalingen van NEUE zijn gestegen.
Dividendrendement versus markt NeueHealth Dividendrendement versus markt
Hoe verhoudt NEUE dividendrendement zich tot de markt? Segment Dividendrendement Bedrijf (NEUE) n/a Markt onderkant 25% (US) 1.3% Markt Top 25% (US) 4.3% Gemiddelde industrie (Healthcare) 1.6% Analist prognose (NEUE) (tot 3 jaar) 0%
Opmerkelijk dividend: Het dividendrendement van NEUE kan niet worden vergeleken met dat van de onderste 25% van de dividendbetalers, aangezien het bedrijf geen recente uitbetalingen heeft gerapporteerd.
Hoog dividend: Het dividendrendement van NEUE kan niet worden vergeleken met dat van de top 25% van de dividendbetalers, aangezien het bedrijf geen recente uitbetalingen heeft gerapporteerd.
Winstuitkering aan aandeelhouders
Verdiendekking: Er zijn onvoldoende gegevens om de payout ratio NEUE te berekenen en vast te stellen of de dividendbetalingen worden gedekt door de winst.
Contante uitbetaling aan aandeelhouders
Kasstroomdekking: De duurzaamheid van het dividend kan niet worden berekend, omdat NEUE geen uitbetalingen heeft gerapporteerd.
Ontdek bedrijven met een sterk dividend Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"control","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
